Q5101

HCPCS

Injection, zarxio

Official HCPCS Level II long descriptor

Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram

HCPCS Level II code Q5101 is maintained by CMS and is active in the current quarterly release.

Short descriptor

Injection, zarxio

Added to HCPCS: 2015-07-01

Nearby codes in Q5

Q5006Hospice in hospice facility
Q5007Hospice in ltch
Q5008Hospice in inpatient psych
Q5009Hospice/home hlth, place nos
Q5010Hospice home care in hospice
Q5098Inj ustekinumab-srlf, 1 mg
Q5099Inj ustekinumab-stba, 1 mg
Q5100Inj ustekinumab-kfce, 1 mg
Q5103Injection, inflectra
Q5104Injection, renflexis
Q5105Inj retacrit esrd on dialysi
Q5106Inj retacrit non-esrd use
Q5107Inj mvasi 10 mg
Q5108Injection, fulphila
Q5110Nivestym
Q5111Injection, udenyca 0.5 mg

Where this code sits

HCPCS Level II Q5 codes

Krasyn AI Coder

Get code suggestions automatically as you type notes. Free for 50 analyses.

Install for Chrome — free

Source

HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.